GH vs. HIMS
GH (Guardant Health, Inc.) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — GH in Diagnostics & Research, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 5 years, GH returned 0.19%/yr vs 24.71%/yr for HIMS. At a 0.35 correlation, their price movements are largely independent.
Performance
GH vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GH achieves a 26.13% return, which is significantly higher than HIMS's 3.30% return.
GH
- 1D
- -2.24%
- 1M
- 8.31%
- YTD
- 26.13%
- 6M
- 27.13%
- 1Y
- 162.17%
- 3Y*
- 53.63%
- 5Y*
- 0.19%
- 10Y*
- —
HIMS
- 1D
- -5.44%
- 1M
- 41.22%
- YTD
- 3.30%
- 6M
- -4.31%
- 1Y
- -47.77%
- 3Y*
- 58.52%
- 5Y*
- 24.71%
- 10Y*
- —
GH vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
GH Guardant Health, Inc. | 26.13% | 234.34% | 12.94% | -0.55% | -72.81% | -22.39% | 64.93% | 1.41% |
HIMS Hims & Hers Health, Inc. | 3.30% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between GH and HIMS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.35 |
The correlation between GH and HIMS shifts across timeframes, from 0.20 (1 year) to 0.39 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
GH:
$16.91B
HIMS:
$7.66B
GH:
-$3.40
HIMS:
-$0.05
GH:
15.19
HIMS:
3.47
GH:
$1.08B
HIMS:
$2.37B
GH:
$701.01M
HIMS:
$1.70B
GH:
-$411.42M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GH vs. HIMS — Risk / Return Rank
GH
HIMS
GH vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Guardant Health, Inc. (GH) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GH | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.30 | ||
| Sortino ratioReturn per unit of downside risk | +3.85 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 0.97 | +0.48 |
| Calmar ratioReturn relative to maximum drawdown | 4.95 | -0.61 | +5.56 |
| Martin ratioReturn relative to average drawdown | 12.27 | -1.00 | +13.26 |
Loading charts...
Drawdowns
GH vs. HIMS - Drawdown Comparison
The maximum GH drawdown since its inception was -91.03%, roughly equal to the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for GH and HIMS.
Loading charts...
Drawdown Indicators
| GH | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.03% | -87.29% | -3.74% |
Max Drawdown (1Y)Largest decline over 1 year | -32.98% | -78.06% | +45.08% |
Max Drawdown (3Y)Largest decline over 3 years | -59.79% | -78.88% | +19.09% |
Max Drawdown (5Y)Largest decline over 5 years | -87.84% | -78.88% | -8.96% |
Current DrawdownCurrent decline from peak | -28.07% | -51.21% | +23.14% |
Average DrawdownAverage peak-to-trough decline | -51.50% | -43.26% | -8.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.27% | 48.60% | -35.33% |
Volatility
GH vs. HIMS - Volatility Comparison
The current volatility for Guardant Health, Inc. (GH) is 13.07%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 23.38%. This indicates that GH experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GH | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.07% | 23.38% | -10.31% |
Volatility (6M)Calculated over the trailing 6-month period | 38.12% | 69.21% | -31.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.29% | 97.84% | -39.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.65% | 83.58% | -15.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.23% | 77.39% | -9.16% |
Dividends
GH vs. HIMS - Dividend Comparison
Neither GH nor HIMS has paid dividends to shareholders.
Financials
GH vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Guardant Health, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GH vs. HIMS - Profitability Comparison
GH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Guardant Health, Inc. reported a gross profit of 196.75M and revenue of 301.67M. Therefore, the gross margin over that period was 65.2%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
GH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Guardant Health, Inc. reported an operating income of -121.35M and revenue of 301.67M, resulting in an operating margin of -40.2%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
GH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Guardant Health, Inc. reported a net income of -112.08M and revenue of 301.67M, resulting in a net margin of -37.2%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
GH and HIMS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (23.38%) compared to GH (13.07%). In terms of maximum drawdown, GH dropped -91.03% vs HIMS's -87.29%.
GH currently has the higher Sharpe Ratio (2.80 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GH and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer